Q1 2026 Bionano Genomics Inc Earnings Call Transcript

May 13, 2026 / 08:30 PM GMT

Transcript 10-Q8-K

Key Points

Positve

Bionano Genomics Inc (BNGO) reported a 17% year-over-year increase in flow cell sales, reaching a record volume for any Q1.
Consumable revenue increased by 20% year-over-year, indicating strong growth and alignment with the company's strategy.
The company achieved a 49% gross margin in Q1 2026, up from 46% in Q1 2025, reflecting improved operational efficiencies.
Significant reimbursement milestones were achieved with a 47% increase in payment determination for OGM in hematologic malignancies and a new CPT code for constitutional genetic disorders.
Publications describing the utility of OGM for rare diseases increased by 56% year-over-year, with a 158% increase in genomes published, showcasing growing academic and clinical interest.

Negative

Software revenue decreased by 40% year-over-year due to a large prior year sale that fulfilled customer needs for 2025 and 2026.
The company does not expect to reach cash flow break-even by the end of 2026, indicating ongoing financial challenges.
Despite revenue growth, the company faced supply constraints in flow cell production, although improvements are expected.
Operating expenses increased to $9.1 million in Q1 2026 from $8.5 million in Q1 2025, indicating higher costs.
The company is undergoing a leadership transition, which may pose risks to business continuity and strategic execution.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BNGO.OQ - Bionano Genomics Inc
Q1 2026 Bionano Genomics Inc Earnings Call
May 13, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day, and welcome to the BioNano First Quarter 2026 Earnings Conference Call. Today's conference is being recorded.

At this time, I would like to turn the conference over to Webb Campbell from Gilmartin Group. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Liz, and good afternoon, everyone. Welcome to the Bionano First Quarter 2026 Financial Results Conference Call. On the call today is Dr. Al Luterer, Chairman and Interim CEO of Bionano and Mark Adamchak, Bionano's Vice President of Accounting and Principal Accounting Officer. After

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.